State Street’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.41B | Sell |
|
|||||
|
2025
Q2 | $1.03B | Sell |
|
|||||
|
2025
Q1 | $909M | Sell |
|
|||||
|
2024
Q4 | $805M | Sell |
|
|||||
|
2024
Q3 | $954M | Sell |
|
|||||
|
2024
Q2 | $859M | Buy |
|
|||||
|
2024
Q1 | $477M | Buy |
|
|||||
|
2023
Q4 | $597M | Buy |
|
|||||
|
2023
Q3 | $514M | Buy |
|
|||||
|
2023
Q2 | $549M | Buy |
|
|||||
|
2023
Q1 | $572M | Buy |
|
|||||
|
2022
Q4 | $662M | Sell |
|
|||||
|
2022
Q3 | $560M | Sell |
|
|||||
|
2022
Q2 | $436M | Buy |
|
|||||
|
2022
Q1 | $475M | Buy |
|
|||||
|
2021
Q4 | $483M | Buy |
|
|||||
|
2021
Q3 | $529M | Buy |
|
|||||
|
2021
Q2 | $472M | Buy |
|
|||||
|
2021
Q1 | $371M | Sell |
|
|||||
|
2020
Q4 | $365M | Buy |
|
|||||
|
2020
Q3 | $407M | Buy |
|
|||||
|
2020
Q2 | $413M | Sell |
|
|||||
|
2020
Q1 | $325M | Buy |
|
|||||
|
2019
Q4 | $334M | Sell |
|
|||||
|
2019
Q3 | $241M | Buy |
|
|||||
|
2019
Q2 | $210M | Buy |
|
|||||
|
2019
Q1 | $257M | Buy |
|
|||||
|
2018
Q4 | $175M | Buy |
|
|||||
|
2018
Q3 | $209M | Buy |
|
|||||
|
2018
Q2 | $222M | Buy |
|
|||||
|
2018
Q1 | $254M | Buy |
|
|||||
|
2017
Q4 | $254M | Sell |
|
|||||
|
2017
Q3 | $240M | Buy |
|
|||||
|
2017
Q2 | $155M | Sell |
|
|||||
|
2017
Q1 | $111M | Sell |
|
|||||
|
2016
Q4 | $88.4M | Buy |
|
|||||
|
2016
Q3 | $158M | Buy |
|
|||||
|
2016
Q2 | $122M | Buy |
|
|||||
|
2016
Q1 | $122M | Buy |
|
|||||
|
2015
Q4 | $158M | Buy |
|
|||||
|
2015
Q3 | $124M | Buy |
|
|||||
|
2015
Q2 | $176M | Buy |
|
|||||
|
2015
Q1 | $121M | Buy |
|
|||||
|
2014
Q4 | $104M | Sell |
|
|||||
|
2014
Q3 | $86.6M | Buy |
|
|||||
|
2014
Q2 | $67.6M | Sell |
|
|||||
|
2014
Q1 | $95.8M | Buy |
|
|||||
|
2013
Q4 | $91M | Sell |
|
|||||
|
2013
Q3 | $97.8M | Sell |
|
|||||
|
2013
Q2 | $49.3M | Buy |
|